Behavioral interventions for the treatment of obesity in women with or at risk for cardiovascular disease

被引：2

作者：

Bond D.S. ^{[1
]}

Wing R.R. ^{[1
]}

机构：

[1] Brown Alpert Medical School/The Miriam Hospital, Providence, RI, 02903

来源：

Current Cardiovascular Risk Reports | 2009年 / 3卷 / 3期

关键词：

Metformin; Sedentary Behavior; Lifestyle Intervention; Great Weight Loss; Weight Loss Maintenance;

D O I：

10.1007/s12170-009-0034-7

中图分类号：

学科分类号：

摘要：

More than one-third of women in the United States are obese. This fact is of particular concern given that obesity contributes to increased risk of several diseases that affect women, including cardiovascular disease. Even modest weight loss, however, can prevent and improve cardiovascular risk factors in obese women. Behavioral interventions for the treatment of obesity that aim to produce weight loss via modification of diet and exercise habits appear to be particularly effective in this regard. This article summarizes research on the effects of behaviorally produced weight loss on cardiovascular risk, principal strategies to improve behavioral weight loss outcomes, and key components of successful long-term weight maintenance. © 2009 Current Medicine Group, LLC.

引用

页码：219 / 225

页数：6

共 48 条

[1]

Ogden C.L., Yanovski S.Z., Carroll M.D., Flegal K.M., The epidemiology of obesity, Gastroenterology, 132, pp. 2087-2102, (2007)

[2]

Manson J.E., Willett W.C., Stampfer M.J., Et al., Body weight and mortality among women, N Engl J Med, 333, pp. 677-685, (1995)

[3]

Flegal K.M., Graubard P.I., Williamson D.F., Gail M.H., Cause-specific excess deaths associated with underweight, overweight and obesity, Jama, 298, pp. 2028-2037, (2007)

[4]

Zalesin K.C., Franklin B.A., Miller W.M., Et al., Impact of obesity on cardiovascular disease, Endocrinol Metab Clin North Am, 37, pp. 663-684, (2008)

[5]

Gregg E.W., Cheng Y.J., Cadwell B.L., Et al., Secular trends in cardiovascular disease risk factors according to body mass index in US adults, Jama, 293, pp. 1868-1874, (2005)

[6]

Schneider J.G., Tompkins C., Blumenthal R.S., Mora S., The metabolic syndrome in women, Cardiol Rev, 14, pp. 286-291, (2006)

[7]

Visser M., Bouter L.M., McQuillan G.M., Et al., Elevated C-reactive protein levels in overweight and obese adults, Jama, 282, pp. 2131-2135, (1999)

[8]

Shoelson S.E., Herrero L., Naaz A., Obesity, inflammation and insulin resistance, Gastroenterology, 132, pp. 2169-2180, (2007)

[9]

Meyers M.R., Gokce N., Endothelial dysfunction in obesity: etiological role in atherosclerosis, Curr Opin Endocrinol Diabetes Obes, 14, pp. 365-369, (2007)

[10]

Obes Res, 6, SUPPL. 2, pp. 51-209, (1998)

← 1 2 3 4 5 →